Table of Contents Table of Contents
Previous Page  36 / 66 Next Page
Information
Show Menu
Previous Page 36 / 66 Next Page
Page Background

Hyperprogressive disease is frequent in NSCLC patients treated

with anti PD1/PD-L1

•

N=242

Ferrara, ESMO 2017 #1306PD

1 … 31 32 33 34 35 36 37 38 39 40 41 42 … 66  FlippingBook